Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

2
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
2
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

2
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
2
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

2
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
2
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

2
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
2
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

2
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Lactate Dehydrogenase on the Measurement of Blood Bicarbonate.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Ten tips to teach learners to love nephrology (and recruit the next generation).

Clinical kidney journal·2025
Same author

Gut to Stone: The Woes of Malabsorption and Kidney Stone Growth.

Kidney international reports·2025
Same author

Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy.

Expert review of clinical pharmacology·2025
Same author

Metabolic testing in urinary diversion stone formers.

Clinical nephrology·2025
Same author

Renal Physiology Education via Podcast: Channel Your Enthusiasm.

Kidney medicine·2025

Related Experiment Video

Updated: Jun 10, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
11:54

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

8.9K

Viral Nephropathies: Core Curriculum 2024.

Amy A Yau1, Sangeetha Murugapandian2, Ali W Rizvi1

  • 1Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|October 10, 2024
PubMed
Summary

Viral infections can cause kidney disease (viral-associated nephropathy) through direct damage or immune responses. Understanding viral causes, injury mechanisms, and treatments is crucial for patient care.

Keywords:
Glomerular diseaseinfection-related kidney diseasevirus

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Related Experiment Videos

Last Updated: Jun 10, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
11:54

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

8.9K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Area of Science:

  • Nephrology
  • Virology
  • Immunology

Background:

  • Viral-associated nephropathy is a significant global health concern due to the high prevalence of viral infections.
  • Viruses like Hepatitis B, C, HIV, and SARS-CoV-2 are common causes, while others like EBV, CMV, and polyoma virus affect immunosuppressed individuals.
  • Hantavirus and dengue virus present rare but severe kidney manifestations despite high infectivity.

Purpose of the Study:

  • To review common viruses causing kidney disease worldwide.
  • To discuss the pathogenesis and mechanisms of kidney injury in viral nephropathies.
  • To highlight current management principles and antiviral therapy options.

Main Methods:

  • Review of existing literature on viral-associated nephropathy.
  • Analysis of viral mechanisms leading to glomerular and tubulointerstitial lesions.
  • Discussion of direct viral infection versus indirect immune-mediated injury.

Main Results:

  • Viral nephropathies manifest as glomerular and tubulointerstitial lesions in acute and chronic infections.
  • Pathogenesis involves direct viral invasion, immune system activation, and hemodynamic alterations.
  • Genetic factors like APOL1 polymorphisms influence susceptibility in HIV- and SARS-CoV-2-associated nephropathies.

Conclusions:

  • Advances in understanding viral pathogenesis and antiviral therapies improve outcomes for viral-associated nephropathy.
  • Effective management requires awareness of specific viral culprits, injury patterns, and host factors.
  • Further research is needed for viruses with high endemicity but low reported kidney disease incidence.